4-[3-(4-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]-3-N-methyl-1H-pyrazole-3,5-diamine

Catalog No. :
ACVCFU583
CAS No. :
1188305-07-8
Molecular Formula :
C13H14N6O2
Molecular Weight :
286.30

IUPAC Name:4-(3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl)-N3-methyl-1H-pyrazole-3,5-diamine

4-[3-(4-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]-3-N-methyl-1H-pyrazole-3,5-diamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$264.00Login to see priceInquiryInquiry
100mg95%$384.00Login to see priceInquiryInquiry
250mg95%$541.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-[3-(4-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]-3-N-methyl-1H-pyrazole-3,5-diamine
IUPAC Name4-(3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl)-N3-methyl-1H-pyrazole-3,5-diamine
MDL No.MFCD14729562
Molecular FormulaC13H14N6O2
Molecular Weight286.30
SMILESNC1=C(C2=NC(C3=CC=C(OC)C=C3)=NO2)C(NC)=NN1
InChI KeyLLHQAJAAHVPWLO-UHFFFAOYSA-N
Synonym4-(3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl)-5-(methylimino)-2,5-dihydro-1H-pyrazol-3-amine;1H-Pyrazole-3,5-diamine, 4-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-N3-methyl-;4-[3-(4-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]-3-N-methyl-1H-pyrazole-3,5-diamine
CAS No.1188305-07-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACVCFU583 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVCFU583 route product structure diagram
    ACVCFU5831188305-07-8
Inquiry

2. ACVCFU583 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVCFU583 route product structure diagram
    ACVCFU5831188305-07-8
Inquiry

Comments (0)